INTRODUCTION
Dementia with Lewy bodies (DLB) is characterized by progressive cognitive, neuropsychiatric, motor, autonomic, and sleep impairment. Pharmacological interventions developed with disease-modifying intent have entered clinical testing, but their biological rationale and adequacy of evaluation remain uncertai...
Deirdre M. O'Shea, Shanell Disla, Alyssa Gosling et al.· Expert Review of Clinical Ph...· 0 citations
Preliminary evidence is provided that a cognition-trained DNAm signature captures variation in later cognitive performance not fully represented by baseline cognition or available ADRD blood biomarkers.
Deirdre M. O'Shea, Lily Wang, David Lukacsovich et al.· The journals of gerontology....· 0 citations
AD blood‐based biomarker–cognition associations were domain‐differentiated and context‐dependent: Concurrent associations did not reliably indicate associations with cognition 6 years later, and only p‐tau181 showed formal evidence of relative memory‐versus‐executive selectivity.
Deirdre M. O'Shea, James E. Galvin· Alzheimer's & Dementia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.